Biotheus
Closed- Website
- biotheus.com
- Total Funding
- $26.0M
- Last Round
- $26.0M Series BMar 2021
- Rounds
- 3
About
Biotheus is a clinical development stage company treating cancer and autoimmune diseases through next-generation therapeutics.
Summary
Biotheus is a Life Sciences company. It has raised $26.0M in total across 3 rounds, most recently a $26.0M Series B round in Mar 2021. Investors include BioNTech, General Atlantic and IDG Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.